Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 Dec;5(6):649-55 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/7165009.
Compare quality appraisals for each clinical question
- What information and assessments are required prior to administering cancer therapy?
- What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?
- What is the optimal systemic therapy for stage IV inoperable NSCLC?